Zobrazeno 1 - 3
of 3
pro vyhledávání: '"T J, Melink"'
Autor:
A R, Hanauske, T J, Melink, G S, Harman, G M, Clark, J B, Craig, J M, Koeller, D H, Boldt, B, Kantor, D L, Kisner, G, Orczyk
Publikováno v:
Cancer research. 48(18)
Carbetimer (carbethimer, N-137, NED-137, carboxyimamidate) is a low molecular weight polyelectrolyte with antitumor activity in a variety of tumor models. This phase I trial evaluated a single dose of carbetimer infused over 1-2 h every 28 days. Fort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::536250765d62d8a4363942a1a8b789a2
https://pubmed.ncbi.nlm.nih.gov/2842047
https://pubmed.ncbi.nlm.nih.gov/2842047
Autor:
T J, Melink, D D, Von Hoff, J G, Kuhn, M R, Hersh, L A, Sternson, T F, Patton, R, Siegler, D H, Boldt, G M, Clark
Publikováno v:
Cancer research. 45(6)
Tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide, TCAR, Riboxamide, NSC 286193) is a novel C-nucleoside with antitumor activity against several murine tumor models, including Lewis lung carcinoma. The mechanism whereby this compound exerts it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::68f38277f873b72c189d127ec0e9350a
https://pubmed.ncbi.nlm.nih.gov/3986813
https://pubmed.ncbi.nlm.nih.gov/3986813
Autor:
T J, Melink
Publikováno v:
Cancer treatment and research. 42
The role of nurses in the development, conduct, and reporting of phase I trials has in recent years become that of a clinical investigator. In collaboration with physicians and other team members, nurses are involved in every aspect of the clinical t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b8e85b2b79fdf171d2e97e3dd706da9e
https://pubmed.ncbi.nlm.nih.gov/2577100
https://pubmed.ncbi.nlm.nih.gov/2577100